We are live on ! Find out more
TPTX

Turning Point Therapeutics, Inc. Common Stock

Delisted

TPTX was delisted on the 16th of August, 2022.

119 hedge funds and large institutions have $1.33B invested in Turning Point Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 47 increasing their positions, 33 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 33

0% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 23

1% less funds holding

Funds holding: 120119 (-1)

24% less capital invested

Capital invested by funds: $1.76B → $1.33B (-$427M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

26% less call options, than puts

Call options by funds: $1.2M | Put options by funds: $1.63M

Holders
119
Holders Change
-1
Holders Change %
-0.83%
% of All Funds
2.62%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
23
Increased
47
Reduced
33
Closed
23
Calls
$1.2M
Puts
$1.63M
Net Calls
-$430K
Net Calls Change
-$200K
Name Holding Trade Value Shares
Change
Change in
Stake
Rafferty Asset Management
126
Rafferty Asset Management
New York
-$1.71M -27,392 Closed
AC
127
Athanor Capital
New York
-$1.16M -18,600 Closed
Voloridge Investment Management
128
Voloridge Investment Management
Florida
-$964K -15,478 Closed
SSA
129
Schonfeld Strategic Advisors
New York
-$604K -9,700 Closed
WCA
130
Windsor Creek Advisors
Vermont
-$489 -7,845 Closed
Jane Street
131
Jane Street
New York
-$416K -6,674 Closed
D.E. Shaw & Co
132
D.E. Shaw & Co
New York
-$264K -4,241 Closed
TI
133
Trexquant Investment
Connecticut
-$243K -3,895 Closed
GPCM
134
Granite Point Capital Management
Massachusetts
-$230K -3,700 Closed
Bank of Montreal
135
Bank of Montreal
Ontario, Canada
-$217K -3,484 Closed
Point72 Asset Management
136
Point72 Asset Management
Connecticut
-$131K -2,100 Closed
TRCT
137
Tower Research Capital (TRC)
New York
-$35K -566 Closed
AS
138
Altshuler Shaham
Israel
-$16K -264 Closed
LC
139
Lindbrook Capital
California
-$2K -32 Closed

TPTX Hedge Fund Activity: Q1 2020 in Review

119 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Turning Point Therapeutics, Inc. Common Stock (TPTX) for Q1 2020, worth a combined $1.33B — down 24% from $1.76B a quarter earlier.

Fund positioning in TPTX was balanced in Q1 2020: 23 funds opened new positions, 23 closed out, 47 added to existing stakes and 33 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $82.3M. The largest seller was venBio Partners, cutting an estimated $29.1M.

  • 119 institutional investors held Turning Point Therapeutics, Inc. Common Stock (TPTX) as of Q1 2020, down from 120 in Q4 2019.
  • Funds reported $1.33B of Turning Point Therapeutics, Inc. Common Stock stock for Q1 2020, down 24% quarter-over-quarter.
  • 23 funds opened new Turning Point Therapeutics, Inc. Common Stock positions in Q1 2020 and 23 closed out, a net change of 0 holders.
  • The largest Turning Point Therapeutics, Inc. Common Stock buyer in Q1 2020 was Wellington Management Group, an estimated $82.3M added.
  • The largest Turning Point Therapeutics, Inc. Common Stock seller in Q1 2020 was venBio Partners, an estimated $29.1M sold.

Based on aggregated 13F filings for Q1 2020.